Aimei Health TechnologyAFJK
13F holders, Q2 2026 (June 30)7holders −1
1new positions
2sold out
$11.39avg. 13F price*
At the end of Q2 2026, 7 institutions reported holding Aimei Health Technology Co. (AFJK) in their 13F filings, down 1 from Q1 2026. 1 opened new positions and 2 sold out. The largest holders were First Trust Capital Management L.P. ($7.7M), Glazer Capital, LLC ($1.5M) and Clear Street Group Inc. ($948K).
- Company
- Aimei Health Technology Co.
- CUSIP
- G01341109
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $3K |
| Exits | 2 | $10K |
All 13F filers, Q1 2026 → Q2 2026: 157 shares bought and 430 shares sold, net −273 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 7 holders
| First Trust Capital Management L.P. | 0.45% | No change | 680,000 | $7.7M |
| Glazer Capital, LLC | 0.04% | No change | 133,744 | $1.5M |
| Clear Street Group Inc. | 0.00% | No change | 83,337 | $948K |
| Karpus Management, Inc. | 0.03% | No change | 77,125 | $888K |
| SBI Securities Co., Ltd. | 0.00% | New | 112 | $3K |
| UBS Group AG | 0.00% | Add +321.4% | 59 | $2K |
| Morgan Stanley | 0.00% | Reduce -14.0% | 43 | $1K |
"% of holder's portfolio" is AFJK's weight in each manager's 13F, not the share of Aimei Health Technology Co. the manager owns.